A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
Clinical trial NCT07232719 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07232719
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-17
- Primary completion
- 2027-07-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.